Pacific Biosciences
CEO Christian Henry said he is hopeful seven Vega placements in Q4 and other product launches last year will help PacBio return to growth in 2025.
Currently being offered to patients with certain sensory disorders as a routine clinical test, the company plans to expand the assay to other genetic disorders.
Pacific Biosciences, GeneDx, Google Health Partner With New York Center for Rare Diseases
A pilot project will perform genomic testing on 50 patient-parent trios to see if PacBio's long-read sequencing can identify genetic alterations.
Children's Mercy Clinical Validation of Long-Read WGS Assay Sets Stage for Frontline Evaluation
Premium
The so-called "five-base" assay, which includes methylation calls thanks to PacBio's Revio instrument, will be evaluated as a frontline test for critically ill newborns.
Pacific Biosciences, GeneDx, UW Collaborate on Google-Funded Study of WGS in Neonatal Care
Google will contribute expertise on informatics methods and provide an undisclosed amount of funding, including for reagents, to the project.